Mesenchymal stem cells as Trojan horses for GDNF delivery in ALS

Molecular Therapy

Volumn 16, Issue 12, 2008, Pages 1905-1906

  Kaspar, Brian K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LENTIVIRUS VECTOR; NEUROTROPHIC FACTOR; SOMATOMEDIN C; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; CELL DIFFERENTIATION; CELL MIGRATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; GENE MUTATION; HUMAN; MESENCHYMAL STEM CELL; NERVE CELL NECROSIS; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NOTE; PHENOTYPE; PREVALENCE; STEM CELL GENE THERAPY; UNSPECIFIED SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM;

EQUIDAE;

EID: 56749133335     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.216     Document Type: Note

References (19)

1. Cleveland, DW and Rothstein, JD (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev 2: 806-819.
2. Rowland, LP and Shneider, NA (2001). Amyotrophic lateral sclerosis. N Engl J Med 344: 1688-1700.
3. Clement, AM, Nguyen, MD, Roberts, EA, Garcia, ML, Boillee, S, Rule, M et al. (2003). Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302: 113-117.
4. Boillee, S, Vande Velde, C and Cleveland, DW (2006). ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59.
5. Boillee, S, Yamanaka, K, Lobsiger, CS, Copeland, NG, Jenkins, NA, Kassiotis, G et al. (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392.
6. Miller, TM, Kim, SH, Yamanaka, K, Hester, M, Umapathi, P, Arnson, H et al. (2006). Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 103: 19546-19551.
7. Yamanaka, K, Boillee, S, Roberts, EA, Garcia, ML, McAlonis-Downes, M, Mikse, OR et al. (2008). Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci USA 105: 7594-7599.
8. Yamanaka, K, Chun, SJ, Boillee, S, Fujimori-Tonou, N, Yamashita, H, Gutmann, DH et al. (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11: 251-253.
9. Gurney, ME, Pu, H, Chiu, AY, Dal Canto, MC, Polchow, CY, Alexander, DD et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775.
10. Howland, DS, Liu, J, She, Y, Goad, B, Maragakis, NJ, Kim, B et al. (2002). Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic: Lateral sclerosis (ALS). Proc Natl Acad Sci USA 99: 1604-1609.
11. Suzuki, M, McHugh, J, Tork, C, Shelley, B, Hayes, A, Bellantuono, I et al. (2008). Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 116: 2002-2010.
12. Klein, SM, Behrstock, S, McHugh, J, Hoffmann, K, Wallace, K, Suzuki, M et al. (2005). GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 16: 509-521.
13. Suzuki, M, McHugh, J, Tork, C, Shelley, B, Klein, SM, Aebischer, P et al. (2007). GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE 2: E689.
14. Li, W, Brakefield, D, Pan, Y, Hunter, D, Myckatyn, TM and Parsadanian, A (2007). Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp Neurol 203 457-471.
15. Acsadi, G, Anguelov, RA, Yang, H, Toth, G, Thomas, R, Jani, A et al. (2002). Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy. Hum Gene Ther 13 1047-1059.
16. Kaspar, BK, Llado, J, Sherkat, N, Rothstein, JD and Gage, FH (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301: 839-842.
17. Mohajeri, M.H, Figlewicz, DA and Bohn, MC (1999). Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum Gene Ther 10: 1853-1866.
18. Wang, LJ, Lu, YY, Muramatsu, S, Ikeguchi, K, Fujimoto, K, Okada, T et al. (2002). Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci 22: 6920-6928.
19. Dodge, JC, Haidet, AM, Yang, W, Passini, MA, Hester, M, Clarke, J et al. (2008). Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol Ther 16: 1056-1064.